CoChat

Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up

Lahner, Edith, Esposito, Gianluca, Pilozzi, Emanuela, Purchiaroni, Flaminia, Corleto, Vito D, Di Giulio, Emilio, Annibale, Bruno · 2015 · Scandinavian Journal of Gastroenterology

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Atrophic gastritis (AG) is a risk condition for gastric cancer and type I gastric carcinoids. Recent studies assessing the overall risk of gastric cancer and carcinoids in AG at long-term follow up are lacking. This study aimed to investigate in a prospective cohort of AG patients the occurrence of gastric cancer and carcinoids at long-term follow up. METHODS: A total of 200 AG patients from a prospective cohort (67% female, median age 55 years) with a follow up of 7.5 (range: 4-23.4) years were included. Inclusion criteria were presence of AG and at least one follow-up gastroscopy with biopsies at ≥4 years after AG diagnosis. Follow-up gastroscopies at 4-year intervals were performed. RESULTS: Overall, 22 gastric neoplastic lesions were detected (crude incidence 11%). Gastric cancer was diagnosed in four patients at a median follow up of 7.2 years (crude incidence 2%). Eleven type I gastric carcinoids were detected at a median follow up of 5.1 years (crude incidence of 5.5%). In seven patients, six low-grade and one high-grade dysplasia were found. The annual incidence rate person-year were 0.25% (95% confidence interval [CI]: 0.067-0.63%), 0.43% (95% CI: 0.17-0.89%), and 0.68% (95% CI: 0.34-1.21%) for gastric cancer, dysplasia, and type I-gastric carcinoids, respectively. The incidence rates of gastric cancer and carcinoids were not different (p = 0.07). CONCLUSION: This study shows an annual incidence rate of 1.36% person-year for gastric neoplastic lesions in AG patients at long-term follow up. AG patients are similarly exposed to gastric cancer and type I gastric carcinoids.

Overview

Integrity signals

Registry

Crossref · 10.3109/00365521.2015.1010570

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 46 references

Research works printed but not linked: 4

  1. Correa P, 1992, Cancer Res, 52, 6735
  2. Bordi C, 1998, Yale J Biol Med, 71, 273
  3. Bordi C, 1995, Am J Surg Pathol, 19, S8
  4. Waldum HL, 2013, Acta Physiol (Oxf)

Cited by

See all 103

Metadata

Authors
Lahner, E., Esposito, G., Pilozzi, E., Purchiaroni, F., Corleto, V. D., Di Giulio, E., & Annibale, B.
Affiliations
Azienda Ospedaliera Sant'Andrea (IT)
Corresponding author
Annibale, Bruno
Venue
Scandinavian Journal of Gastroenterology
Published
2015-02-03
Volume
50
Issue
7
Pages
856-865
ISSN
  • 0036-5521 (ISSN-L)
  • 1502-7708
OpenAlex
W2116777095
Cited by
97
References
47
Citations by year
2026: 3 · 2025: 10 · 2024: 13 · 2023: 3 · 2022: 8 · 2021: 16 · 2020: 18 · 2019: 7 · 2018: 6 · 2017: 7 · 2016: 2 · 2015: 4
FWCI
6.38
Type
journal article
Language
en
Open access
closed
Locations
  • Scandinavian Journal of Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Funders
Sapienza Università di Roma
Topics
  • Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
  • Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
Keywords
atrophic gastritis, gastric cancer, stomach neoplasms, dysplasia, incidence, long-term follow-up, risk factors
MeSH terms
Adult, Aged, Aged, 80 and over, Biopsy, Carcinoid Tumor, Female, Gastritis, Atrophic, Gastroscopy, Humans, Male, Middle Aged, Neoplasm Staging, Regression Analysis, Risk Factors, Stomach Neoplasms, Cohort Studies, Multivariate Analysis, Helicobacter pylori, Kaplan-Meier Estimate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. https://app.cochat.ai/papers/10.3109/00365521.2015.1010570
The paper
Lahner, E., Esposito, G., Pilozzi, E., Purchiaroni, F., Corleto, V. D., Di Giulio, E., & Annibale, B. (2015). Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. Scandinavian Journal of Gastroenterology. https://doi.org/10.3109/00365521.2015.1010570

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.